期刊文献+

急性冠状动脉综合征患者住院期间发生出血的临床危险因素评估 被引量:5

Analysis of the risk factors of patients with acute coronary syndrome sufferin hemorrhage during hospitalization
原文传递
导出
摘要 目的探讨急性冠状动脉综合征(ACS)患者住院期间发生出血的相关危险因素。方法收集3807例2001年3月至2007年12月中国多省市ACS注册研究(SINO—GRACE)入选患者的临床特征和诊治特点。其中出血组57例,为病例组,在其余未发生出血的3750个病例中按照地域因素(研究中心)进行分层随机抽样,筛选出234例作为对照组。筛选出血的相关因素,应用单因素logistic回归分析找出可能与出血相关的因素;再采用逐步回归法进行多因素条件logistic回归分析,因素入选的判定标准设为P〈0.1,分析ACS患者住院期间发生出血的预测因素。结果(1)与对照组比较,出血组患者年龄较大(P=0.01);进行冠状动脉旁路移植术(CABG)治疗的患者比例较高(P=0.01);既往有出血史、肾功能衰竭史、心力衰竭史的ACS患者住院期间发生出血的比例较高(P〈0.05);应用氯吡格雷和(或)糖蛋白(GP)Ⅱb/Ⅲa受体拮抗剂的患者出血的发生率较高(P〈0.01)。(2)单因素logistic回归分析显示发病年龄、年龄〉70岁、既往有出血史、肾功能衰竭史、心力衰竭史、应用氯吡格雷、GPⅡb/Ⅲa受体拮抗剂与出血相关(OR均〉1.00,P均〈0.05)。诊断为非ST段抬高型心肌梗死、下壁、侧壁心肌梗死、进行CABG手术治疗与出血相关(OR均〉1.00,P均〈0.05)。(3)多因素logistic回归分析显示肾功能衰竭史(OR=19.77,95%CI4.38~89.18,P〈0.01)、应用氯吡格雷(OR=45.94,95%CI9.82—214.96,P〈0.01)、GPⅡb/Ⅲa受体拮抗剂(OR=343.57,95%CI40.39~999.99,P〈0.01)与出血相关;出血病史虽然进入方程,但P值未达到统计学意义(OR=4.77,95%C10.92~24.72,P=0.06)。结论既往有肾功能衰竭史及应用氯吡格雷、糖蛋白Ⅱb/Ⅲa受体拮抗剂可能是ACS患者住院期间发生出血的� Objective To analyze the risk factors related to in-hospital bleeding for patients with acute coronary syndrome (ACS) . Methods Clinical and therapeutic data of 3807 patients who were registered with acute coronary syndrome in SINO-GRACE in China from March 2001 to December 2007 were reviewed. A total of 57 patients were grouped to bleeding group and 234 out of the remaining 3750 patients without bleeding were randomly chosen and served as non-bleeding group. Hemorrhage-related factors were screened and compared between the two groups. Unitary logistic regression analysis was performed to detect the possible factors related to hemorrhage. Factors with P 〈 0. 1 were further analyzed by stepwise regression method and muhivariate conditional logistic regression analyses. Results ( 1 ) Age, history of coronary artery bypass graft ( CABG), previous hemorrhage, renal failure and heart failure as well incidence of acute coronary syndrome were significantly higher in bleeding group than in non-bleeding group (all P≤0. 05). Patients were more often treated with clopidogrel and glycoprotein (GP) Ⅱb/Ⅲa receptor antagonist in bleeding group than in non-bleeding group. (2) Single factor logistic regression analysis showed that age 〉 70 years, history of previous bleeding, renal failure, heart failure, clopidogrel and GP Ⅱb/Ⅲa receptor antagonists use, non-ST-segment elevation myocardial infarction, inferior wall, lateral myocardial infarction, CABG were risk factors for bleeding ( all P 〈 0. 05). (3) Multivariate logistic regression analysis showed that history of renal failure ( OR = 19. 77,95% CI 4. 38 - 89. 18, P 〈 0. 01 ) and clopidogrel ( OR = 19. 77, 95% CI 4. 38 - 89. 18, P 〈 0. 01 ) and GP Ⅱb/Ⅲa receptor antagonist ( OR = 343.57,95% CI 40. 39 - 999.99, P 〈 0.01 ) use were the independent risk factors for bleeding. Conclusion Our results show that renal failure history and clopidogrel and GP Ⅱb/Ⅲa receptor antagonist use are independent risk fact
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第11期902-907,共6页 Chinese Journal of Cardiology
关键词 冠状动脉疾病 出血 危险因素 Coronary disease Hemorrhage Risk factors
  • 相关文献

参考文献16

  • 1Rao SV, O' Grady K, Pieper KS, et al. hnpact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol,2005,96 : 1200-1206. 被引量:1
  • 2Manonkian SV. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol, 2009,104(5 Suppl) :9C-15C. 被引量:1
  • 3沈杰,张奇,张瑞岩,张建盛,胡健,杨震坤,张宪,郑爱芳,沈卫峰.替罗非班在急性冠脉综合征患者中应用的安全性和出血相关因素分析[J].临床内科杂志,2007,24(1):14-17. 被引量:17
  • 4Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J,2011,32 : 1854-1864. 被引量:1
  • 5宋现涛,吕树铮,陈韵岱,苑飞,林运,田锐,陈欣,金泽宁,周渊,葛长江,孟康,柳弘.经皮冠状动脉介入治疗后患者住院期间合并上消化道出血分析[J].中华心血管病杂志,2007,35(4):308-311. 被引量:36
  • 6李小鹰.急性冠状动脉综合征患者阿司匹林与其他抗栓药物联合应用的出血风险及其防治[J].中华心血管病杂志,2010,38(12):1057-1059. 被引量:6
  • 7Shalev A, Zahger D, Novack V, et al. Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int J Cardiol,2012,157:386-390. 被引量:1
  • 8McCollum M,Stringer KA, Wittkowsky AK, et al. Discrepancies in identification of bleeding events after percutaneous coronary Intervention. Pharmacotherapy, 2007,27 : 36 -40. 被引量:1
  • 9Santopinto J J, Fox KA, Goldberg RJ ,et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronm'y events (GRACE). Heart, 2003,89 : 1003-1008. 被引量:1
  • 10Kontny F. Improving outcomes in acute coronary syndromes-the FRISC Ⅱ trial. Clin Cardiol,2001,24(3 Suppl) :13-17. 被引量:1

二级参考文献27

  • 1ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun NI Jun FANG Yue-hua ZHANG Xian SHEN Wei-feng.One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease[J].Chinese Medical Journal,2006(2):165-168. 被引量:23
  • 2沈杰,沈卫峰.替罗非班在急性冠脉综合征介入治疗中的应用[J].国际心血管病杂志,2006,33(3):156-159. 被引量:72
  • 3Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502. 被引量:1
  • 4Fifth organization to assess strategies in acute ischemic syndromes investigators,Yusuf S,Mehta SR,Chrolavicius S,et al.Comparison of fondaparinux and enoxaparin in acute coronary syndromes.N Engl J Med,2006,354:1464-1476. 被引量:1
  • 5Di Nisio M,Middeldorp S,Büller HR.Direct thrombin inhibitors.N Engl J Med,2005,353:1028-1040. 被引量:1
  • 6Moscucci M,Fox KA,Cannon CP,et al.Predictors of major bleeding in acute coronary syndromes:the global registry of acute coronary events (GRACE).Eur Heart J,2003,24:1815-1823. 被引量:1
  • 7Yang X,Alexander KP,Chen AY,et al.The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes:results from the CRUSADE national quality improvement initiative.J Am Coll Cardiol,2005,46:1490-1495. 被引量:1
  • 8Eikelboom JW,Mehta SR,Anand SS,et al.Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.Circulation,2006,114:774-782. 被引量:1
  • 9Wiviott SD,Braunwald E,McCabe CH,et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes.N Engl J Med,2007,357:2001-2015. 被引量:1
  • 10Kinnaird TD,Stabile E,Mintz GS,et al.Incidence,predictors,and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.Am J Cardiol,2003,92:930-935. 被引量:1

共引文献56

同被引文献32

  • 1王建安.高度关注出血带来的不良后果——2011年ESC非持续性ST段抬高急性冠状动脉综合征患者管理指南解读[J].中国循环杂志,2012,27(S01):24-26. 被引量:2
  • 2O"Gara PT, Kushner FG, Ascheim DD, et al.2013 ACCF/AHA Guideline for the Management of ST- Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].J Am Coil Cardiol,2013,61(4):e78. 被引量:1
  • 3Hamm CW,Bassand JP,Agewall S,et al.ESC guidines for the management of acutecoronary syndromes in patients prosenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST -segment elevation of the European Society of Cardiology (ESC) [J ] .Eur neartJ, 2011,32(23 ) : 2999. 被引量:1
  • 4Steg PG,Huber K,Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions:position paper by the Working Group on Thrombosis of the European Society of Cardiology [J]. Eur Heart J, 2011,32 : 1854. 被引量:1
  • 5Lewandowski P. Subarachnoid haemorrhage imitating acute coronary syndrome as a cause of out of hospital cardiac arrest case report[J]. Anaesthesiol Intensive Ther, 2014, 46 (4) 289-292. 被引量:1
  • 6Hulley JL, Higham DP. 15 Incidence and Outcome from Up- per GI Haemorrhage in the First Year following an Acute Coronary Syndrome[J]. Heart, 2015, 101(suppl 4):A9. 被引量:1
  • 7Anusionwu O, Madanieh R, Ledley G. Bivalirudin use in the elderly for acute coronary syndrome [J]. Br J Med Res, 2015, 5(7):589 592. 被引量:1
  • 8Quraishi S, Arya S. A case of paraplegia post treatment for a- cute coronary syndrome[J]. Br J Hosp Med (Lond), 2013, 74(4) 231. 被引量:1
  • 9Cardin C, Roncalli J, Lairez O. Subarachnoid haemorrhage associated with midventricular Tako-Tsubo syndrome[J]. Int y Cardiol, 2011, 146(2) : e46-e48. 被引量:1
  • 10Delewi R, Zijlstra F, Piek JJ. Acute Coronary Syndromes: Left ventricular thrombus formation after acute myocardial infarction[J]. Heart, 2012, 98(23)..1743-1749. 被引量:1

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部